Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Remepy is pioneering Hybrid Drugs, traditional drugs combined with digital therapeutics that are personalized and enhance the effect of pharmaceutical treatments targeting neurodegenerative diseases, cancer, autoimmune diseases, and degenerative eye diseases.
Lead Product(s): Undisclosed
Therapeutic Area: Neurology Product Name: Undisclosed
Highest Development Status: DiscoveryProduct Type: Undisclosed
Partner/Sponsor/Collaborator: NFX
Deal Size: $15.0 million Upfront Cash: Undisclosed
Deal Type: Financing May 01, 2024